CAD drugs Flashcards

1
Q

Oxygen saturation of blood as it returns to the heart

A

MVO2

SVO2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Myocardial O2 supply determined by these factors:

A

1) perfusion pressure

2) intrinsic vascular resistance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Myocardial O2 demand determined by:

A

1) heart rate
2) contractility
3) wall stress
4) MVO2 = HR x SBP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

First line drugs in CAD

A

Nitrates

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Primary effect of nitroglycerin and related drugs:

A

venous dilation (relaxes all types of smooth muscle)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Secondary effects if nitroglycerin

A

Coronary artery dilation increases supply

Arterial dilation decreases afterload

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Disadvantage for chronic use of nitrates?

A

Drug tolerance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Effect of venous dilation on CO?

A

Venodilation increases venous capacitance –> decrease venous return –> decreasing preload and thus decreasing CO

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How does the consumption of sulfhydryl groups contribute to nitrate tolerance?

A

Sulfhydryl groups on cell membrane are needed for nitrates to enter cell.

No nitrates will enter the cell if nitrates are constantly given.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How does continuous nitrate use cause receptor down-regulation?

A

vasodilation –> larger blood volume –> sympathetic receptors downregulated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

MoA of nitrates:

A

Enter cell membrane –> Nitrification process

NO activates guanylyl cyclase –> increase in cGMP –> Ca release is INHIBITED –> smooth muscle relaxation –> venous dilation

venous dilation –> decreased preload –> decreased CO –> decrease O2 demand

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Nitrate drug interactions:

A

Nitrates cannot be taken with other drugs that use cGMP pathway like PDE-5 inhibitors –> severe hypotension

sildenafil, vardenafil, tadalafil

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Type of beta blocker for CAD treatment?

A

beta 1 blocker

Decreases oxygen demand by decreasing heart rate.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How do beta blockers enhance coronary blood flow?

A

B1 blockage –> Dereased HR –> Increased diastolic perfusion –> increased filling time

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Negative effect of increased filling time?

A

preload inreased –> more force required –> hypertrophy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How do beta blockers reduce MVO2

A

B1 blockage –> Decreased HR and contractility

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Why are B blockers without ISA preferred?

A

ISA = partial agonist at receptor

Therefore they will show less decrease in HR.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Why are non-selective 3rd gen BBs unwanted in CAD patients?

A

3rd gen BB (mostly non-selectives) can have alpha antagonistic effect or stimulate NO release –> increase vasodilation –> profound hypotension –> REFLEX TACHYCARDIA –> higher O2 demand for heart

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

CAD + asthma: what drugs could be used

A

Cardio-selective 3rd gen with partial B2 agonism

Celiprolol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

A patient with CAD is on BBs. What drugs should be avoided?

A

CCBs (verapamil, diltiazem)

Anti-arrhythmics (amiodarone)

They have cardiosuppressive effects leading to profound decrease in HR and CO.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

BB with highest lipid solubility?

A

propanolol

This is why it can cause lethargy, mental depression, hallucinations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

BBs used for early administration after ischemic episodes:

A

IV esmolol

IV metoprolo or atenolol followed by oral metoprolol/atenolol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

BBs used for late administration after ischemic episode:

A

BBs without ISA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Two mechanisms of CCBs

A
  1. Block L-type voltage operated channels (VOCs) and receptor operated channels at membrane
  2. Bind to calcium channel protein
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
CCB group with more vasodilatory effect, less HR effect
dihydropyridines
26
Benzothiazepine
Diltiazem
27
Phenylalkylamine
Verapamil
28
Second Gen CCB are all this type
dihydropyridines
29
Second Gen CCB compared to First Gen?
More vasoselective than 1st
30
Examples of 2nd Gen CCB
amlodipine felodipine nicardipine isradipine
31
Examples of 1st Gen CCB
nefidipine
32
All CCB are metabolized solely by the liver except?
diltiazem
33
Drugs that increase BA of CCB
Cimetidine phenytoin carbamezapine
34
diltiazem and verapmil increase BA of what drugs?
cyclosporine
35
Verapimil effect on digoxin?
increased serum levels
36
Lithium levels increase due to which CCB?
diltiazem
37
CCB that blocks K channel in smooth muscle inhibiting vasodilation
verapamil
38
Effects calcium channel blockers on cardiac muscles
Because of the blocked transmembrane calcium current: 1) decreased contractility 2) decrease SA conduction velocity 3) decreased AV conduction velocity
39
Myocardial selectivity of CCB (ranking):
verapamil > diltiazem > nifedipine (DHPs) verapamil has less vasodilation properties
40
CCB that can more likely cause reflex tachycardia
DHPs --> nifedipine
41
CCB causing decreased HR
verapamil, diltiazem
42
CCB with most sympathetic antagonism
diltiazem | less: verapamil, NONE with nifedipine
43
Preferred CCB with AV conduction abnormalities
nifedipine least effect on AV node
44
Preferred CCB with overt heart failure
All CCB WORSEN (negative inotropic effects) more commonly with non-DHP Amlodipine can be used
45
Preferred CCB for hypotension
non-DHP | diltiezam, verapamil
46
Preferred CCB with tachycardia, flutter, fibrilliation
diltiezam and verapamil antiarrhythmic effects
47
Preferred CCB with unstable angina
NOT nifedipine in combination with nitrates
48
Preferred CCB with non q-wave myocardial infarction
diltiazem can decrease frequency of postinfarction angina
49
Combination of DHP with B-blockers can cause what?
AV block | Ventricular depression
50
Action of angiotensin II
1) vasoconstriction | 2) aldosterone stimulation --> Na and H20 reabsorption
51
How do ACE-I's decrease remodelling
decrease wall stress (load), prevent LV dilatation. Angiotensin II contributes to remodelling through stimulation of the proto-oncogens c-fos, c-jun, c-myc, transforming growth factor beta (TGF-B), through fibrogenesis and apoptosis
52
Why are ACE-I's safe to use in patients with ischemic heart disease?
they do NOT cause reflex sympathetic activation
53
Adverse effects of ACE-I's:
cough angioedema ACE-Inhibitors increase bradykinin which cause cough and angioedema
54
Angiotensin II contributes to remodelling through stimulation of:
Pproto-oncogens c-fos, c-jun, c-myc, transforming growth factor beta (TGF-B), through fibrogenesis and apoptosis
55
ACE inhibitors mechanism:
Vasodilation Decrease aldosterone Increase bradykinin
56
Why do ARBs have more potential for angiotensin block?
ARBs block the receptor AT1. ACE block ACE from forming angiotensin II but other enzymes form angiotensin II.
57
What was the first peptide ARB? Why is it no longer used?
Saralasin Low absorption and short half-life
58
Adverse effects of ARBs
cough, hyperkalemia, LBP, dizziness, headache abnormal taste
59
New drug therapy for myocardial ischemia; rho kinase inhibtor
Fasudil
60
New drug therapy for myocardial ischemia; metabolic modulator
Trimetazidine
61
New drug therapy for myocardial ischemia; Preconditioning
Nicorandil
62
New drug therapy for myocardial ischemia; sinus node inhibition
Ivabradine
63
New drug therapy for myocardial ischemia; Late sodium current inhibition
Ranolazine
64
New CAD prevent ischemic effects by:
targeting metabolic pathways not hemodynamics